ENDOMETRIAL CARCINOMA

Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 3 Completed 1 Terminated 1

Cancer drug combo trial ends early after only 9 patients

Disease control Terminated

This study tested a combination of two drugs, futibatinib and pembrolizumab, in people with a hard-to-treat type of advanced endometrial cancer called microsatellite stable (MSS). The goal was to see if the combo could shrink tumors or slow the cancer. The trial was stopped early…

Matched conditions: ENDOMETRIAL CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

ENDOMETRIAL CARCINOMA

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Cancer drug combo trial ends early after only 9 patients